Autosome Abnormalities
|
group |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chromosome Aberrations
|
group |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hormone sensitive prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Node-positive breast cancer
|
disease |
|
Neoplastic Process
|
40
|
3
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
myeloblastosis
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
72
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Breast Diseases
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
73
|
6
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Carcinoma, Large Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
90
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Large cell neuroendocrine carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
91
|
3
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adenocarcinoma of rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
103
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Melanocytic nevus of skin
|
disease |
Neoplasms
|
Neoplastic Process
|
103
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cystadenocarcinoma, Serous
|
disease |
Neoplasms
|
Neoplastic Process
|
110
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thromboangiitis Obliterans
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
127
|
16
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Progression of non-small cell lung cancer
|
disease |
|
Neoplastic Process
|
151
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Extrapulmonary Small Cell Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
157
|
11
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Inflammatory Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
183
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
PATENT DUCTUS ARTERIOSUS 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
229
|
12
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hematuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
235
|
31
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Basal-Like Breast Carcinoma
|
disease |
|
Neoplastic Process
|
245
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Melanocytic nevus
|
disease |
Neoplasms
|
Neoplastic Process
|
297
|
33
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2008 |
Adult Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
399
|
27
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Childhood Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
399
|
29
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |